Short-term diabetes mellitus induced by STZ has previously demonstrated to modify autonomic control of HR and cause bradycardia which was reversible by insulin administration confirming that these cardiovascular changes were related to metabolic perturbations and not to the direct toxic effect of diabetogenic agent; STZ32. This evidence concerns the gene INS and Bradycardia.